Statistics Collaborative - Design and analysis for biomedical research

PublicationsPublications

Patricia Feeney

  • Anderson RT, Narayan KM, Feeney P, Goff D, Jr., Ali MK, Simmons DL, Sperl-Hillen JA, Bigger T, Cuddihy R, O'Conner PJ, Sood A, Zhang P, Sullivan MD. Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial. Diabetes Care 2011; 34:807-812.
  • Redmon JB, Bertoni A, Connelly S, Feeney P, Glasser S, Glick H, Greenway F, Hesson L, Lawalor M, Montez M, Montgomery B. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with Type 2 Diabetes. Diabetes Care 2010; 33:1153-1158.
  • Mount DL, Feeney P, Fabricatore AN, Coday M, Bahnson J, Byington R, Phelan S, Wilmoth S, Knowler WC, Hramiak I, Osei K, Sweeney ME, Espeland MA. Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials. Clin Trials 2009; 6:416-429.
  • Bertoni AG, Clark JM, Feeney P, Yanovski SZ, Bantle J, Montgomery B, Safford MM, Herman WH, Haffner S, The Look AHEAD Research Group. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complications 2008; 22:1-9.
  • Sullivan M, Anderson R, Aron D, Atkinson H, Bastien A, Chen G, Feeney P, Gafni A, Hwang W, Katz L, Narayan K, Nwachuku C, O’Connor P, Zhang P, ACCORD Study Group. Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. Am J Cardiol 2007; 99:90i-102i.
  • Gerstein H, Riddle M, Kendall D, Cohen R, Goland R, Feinglos M, Kirk J, Hamilton B, Ismail-Beigi F, Feeney P, ACCORD Study Group. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007; 99:34i-43i.